Personalized Smoking Cessation Infographic in COPD

NCT04119934 | Completed

• 1 other identifier: 19-231
• Study Type: observational
• Target: 83
• Locations: 1 country
• Sites: 1

Brief Summary

This study assesses the effect of a personalized smoking cessation infographic on physician smoking cessation counseling rates and smoking cessation pharmacotherapy prescription rates. The study assesses the difference in physician behaviour using an interrupted time series analysis (one-year pre vs. one-year post-intervention). General practitioners, nurse practitioners and respirologists who refer eligible patients (COPD, active smoking) for spirometry at the St. Michael's Hospital Pulmonary Function Lab will receive the infographic. This is a quality improvement initiative. The smoking cessation infographic uses individualized patient data (height, weight, sex, baseline FEV1, etc.) to produce a personalized lung function decline prediction over the next 15 years.

Conditions

Chronic Obstructive Pulmonary Disease (COPD); Smoking Cessation

Keywords

Chronic obstructive pulmonary disease; COPD; smoking cessation; smoking

Outcome Measures

Primary Outcomes (2)

• Proportion of eligible, smoking patients with COPD who receive a smoking cessation counselling intervention

  Using prospective chart review, we will assess the proportion of smoking patients with COPD who receive or are referred to a smoking cessation intervention at or after the index visit, in each analysis period

  12 months, broken into individual time series periods

• Proportions of eligible, smoking patients with COPD who are prescribed or recommended smoking cessation pharmacotherapy

  Using prospective chart review, we will assess the proportion of smoking patients with COPD who are prescribed or recommended smoking cessation pharmacotherapy at or after the index visit, in each analysis period

  12 months, broken into individual time series periods

Secondary Outcomes (8)

• Changes in respiratory medication prescriptions for eligible, smoking patients with COPD

  12 months, broken into individual time series periods

• Changes in recommendations for non-pharmacotherapy smoking cessation strategies for eligible, smoking patients with COPD

  12 months, broken into individual time series periods

• Smoking cessation billing code changes for eligible, smoking patients with COPD.

  12 months, broken into individual time series periods

• Smoking cessation rates for smoking patients with COPD seen a minimum of 6 months after the index visit, in each analysis period.

  6 months

• Smoking reduction rates for smoking patients with COPD seen a minimum of 6 months after the index visit, in each analysis period.

  6 months

Study Arms (2)

Control - None

A retrospective chart review will assess physician/NP behaviour (rates of smoking cessation counselling and prescription of smoking cessation pharmacotherapy) in the one-year pre-intervention period.

Intervention - Smoking cessation infographic

Throughout the intervention period, the personalized smoking cessation infographic will be provided to physicians/NPs (for eligible patients). Chart review will be conducted for the patient's physician/NP within a three-month window of receiving the infographic to assess outcomes.

Behavioral: Smoking Cessation Intervention Tool

Interventions

Smoking Cessation Intervention Tool BEHAVIORAL

A personalized smoking cessation infographic is provided to the physician/NP alongside the patient's regular spirometry report.

Intervention - Smoking cessation infographic

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population will consist of clinicians in primary care and hospital settings in Toronto, Canada.

Eligible clinicians will include respirologists, general practitioners and nurse practitioners who refer patients for spirometry testing at the St. Michael's Hospital Pulmonary Function Lab.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

• Unity Health Toronto: lead

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Related Publications (5)

• Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005 Feb 15;142(4):233-9. doi: 10.7326/0003-4819-142-4-200502150-00005.

  PMID: 15710956 BACKGROUND

• Chapman KR, Bourbeau J, Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med. 2003 Mar;97 Suppl C:S23-31. doi: 10.1016/s0954-6111(03)80022-7.

  PMID: 12647940 BACKGROUND

• Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? 1998. Milbank Q. 2005;83(4):843-95. doi: 10.1111/j.1468-0009.2005.00403.x. No abstract available.

  PMID: 16279970 BACKGROUND

• Zafari Z, Sin DD, Postma DS, Lofdahl CG, Vonk J, Bryan S, Lam S, Tammemagi CM, Khakban R, Man SFP, Tashkin D, Wise RA, Connett JE, McManus B, Ng R, Hollander Z, Sadatsafavi M. Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. CMAJ. 2016 Oct 4;188(14):1004-1011. doi: 10.1503/cmaj.151483. Epub 2016 Aug 2.

  PMID: 27486205 BACKGROUND

• Voncken-Brewster V, Tange H, de Vries H, Nagykaldi Z, Winkens B, van der Weijden T. A randomized controlled trial evaluating the effectiveness of a web-based, computer-tailored self-management intervention for people with or at risk for COPD. Int J Chron Obstruct Pulmon Dis. 2015 Jun 8;10:1061-73. doi: 10.2147/COPD.S81295. eCollection 2015.

  PMID: 26089656 BACKGROUND

Related Links

• Statistics Canada. Canadian Tobacco Use Monitoring Survey (CTUMS): Detailed Information from February to June 2006

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Health Behavior; Behavior

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 7, 2019
• First Posted: October 9, 2019
• Study Start: January 9, 2023
• Primary Completion: July 31, 2024
• Study Completion: July 31, 2024
• Last Updated: July 7, 2026

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)